Companies: 10,795·Total market cap: $144.5T
ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc.

ALXONASDAQHealthcare● Active
$1.57
+$0.03(+1.95%)
Market Cap$211263780
P/E Ratio
52W High$2.66
52W Low$0.404
Overview

ALX Oncology Holdings Inc. (ALXO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ALXO · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.65alxo eps ttm · alxo earnings per shareEarnings history
PE Ratio (TTM)alxo pe ratio ttm · alxo price to earningsPE Ratio deep dive
Revenue (TTM)0.00alxo revenue ttm · alxo annual revenueFull revenue history
Dividend YieldNo Dividenddoes alxo pay dividends · alxo dividend yieldDividend history
Shares Outstanding53.7Malxo shares outstanding · alxo floatShares outstanding history
Next EarningsAug 11, 2026Est.alxo earnings date · alxo next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
alx oncology holdings inc. revenue · alxo revenue 2025
FY 2025Net Income-$101.7M▲ +24.59% YoY
202320242025
alx oncology holdings inc. net income · alxo profit 2025
FY 2025EPS$-1.90▲ +26.36% YoY
202320242025
alxo eps · alx oncology holdings inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$88.9MEPS: $-1.65View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy7 analystsis alxo a buy · alxo analyst rating
Strong Buy
0
Buy
6
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$4.00Low
$1.57Current
$4.00Avg Target154.78% upside
$4.00High
alxo price target · alxo 12 month forecast

Total: 7 · Buy rate: 85.7%

The ALXO analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $4.00, representing +154.78% upside from the current price of $1.57.

Stock Performance

Full History
1D+1.95%
1W-11.30%
1M-24.52%
3M-28.96%
YTD+38.94%
1Y+171.30%
5Y-97.34%

About ALX Oncology Holdings Inc.

CEOJason W. Lettmann
IPO DateJul 17, 2020
Employees65
CountryUS

ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology firm focused on developing innovative therapies for cancer patients. At the forefront of its pipeline is ALX148, a CD47 blocking therapeu…

what is alx oncology holdings inc. · alxo stock overview · alx oncology holdings inc. company profile · who is alx oncology holdings inc. ceo · alxo NASDAQ · alx oncology holdings inc. headquarters · alx oncology holdings inc. business segments

About Stock Overview & Key Data

ALX Oncology Holdings Inc. (ALXO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 17, 2020. As of the latest trading session, ALXO stock price is $1.57, with a market capitalization of $211.3M. The stock has returned +171.30% over the past 12 months and +38.94% year-to-date.

According to 7 Wall Street analysts, the consensus rating for ALX Oncology Holdings Inc. stock is Buy, with an average 12-month price target of $4.00. In fiscal year 2025, ALX Oncology Holdings Inc. reported revenue of — and net income of -$101.7M. For detailed data — including ALX Oncology Holdings Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, ALX Oncology Holdings Inc. (ALXO) stock price is $1.57. The stock is traded on NASDAQ under the ticker symbol ALXO. The 52-week range is $0.40 – $2.66.

ALXO stock priceALXO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice